Who
Daan Van Well
Chief Legal Officer
Company insider
Files Form 4 as: Chief Legal Officer, SOPHiA GENETICS SA.
In numbers
- Trades disclosed
- 27
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $283K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 19 Mar 2026
- Last trade
- 5 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 7 Oct 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $50K6,168 at $8.12 | filing |
| 11 Sep 2026filed 14 Sep 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $47K6,168 at $7.63 | filing |
| 11 Sep 2026filed 14 Sep 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $47K6,168 at $7.63 | filing |
| 19 May 2026filed 20 May 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $3,149684 at $4.60 | filing |
| 19 May 2026filed 20 May 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $3,146684 at $4.60 | filing |
| 20 Apr 2026filed 21 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $3,554684 at $5.20 | filing |
| 20 Apr 2026filed 21 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $3,557684 at $5.20 | filing |
| 10 Apr 2026filed 14 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $11K2,400 at $4.67 | filing |
| 10 Apr 2026filed 14 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $11K2,400 at $4.67 | filing |
| 9 Apr 2026filed 10 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $9,4241,988 at $4.74 | filing |
| 9 Apr 2026filed 10 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $9,4231,988 at $4.74 | filing |
| 8 Apr 2026filed 10 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $14K2,861 at $4.85 | filing |
| 8 Apr 2026filed 10 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $14K2,861 at $4.85 | filing |
| 7 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $12K2,400 at $4.87 | filing |
| 7 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $12K2,400 at $4.87 | filing |
| 6 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $13K2,705 at $4.86 | filing |
| 6 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Sold | $13K2,705 at $4.86 | filing |
| 2 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAPayments & Processors | SEC FORM 4 Code A | —97,536 at $0.00 | filing |
| 2 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAoption or derivative · Payments & Processors | SEC FORM 4 Code A | —142,216 at $0.00 | filing |
| 2 Apr 2026filed 8 Apr 2026 | SOPH SOPHiA GENETICS SAoption or derivative · Payments & Processors | SEC FORM 4 Code A | —142,216 at $0.00 | filing |
News
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 5,000 Shares of Company StockSOPH · dailypolitical.com · 14 Oct 2026Critical Analysis: SOPHiA GENETICS (NASDAQ:SOPH) & Weave Communications (NYSE:WEAV)SOPH · themarketsdaily.com · 9 Oct 2026Myriad Genetics, SOPHiA GENETICS Partner With AstraZeneca On Prostate Cancer PrGISSOPH · rttnews.com · 8 Oct 2026
0 headlines in the last 90 days name Daan Van Well; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.